Latest News

FDA Releases Draft Guidance for Biosimilar Interchangeability
Guidance intends to help sponsors demonstrate Interchangeability with a reference product.
Real-time reporting of patient symptoms has shown proven health benefits.
Individuals enrolled in high-deductible health plans face thousands in out of pocket costs.
Histone H3 protein is abnormal or incorrectly modified in 15% of patients with head and neck cancer.
Study confirms safety and efficacy of Lu-177-PSMA-17 radioligand therapy for metastatic castration-resistant prostate cancer.
South African Pharmacy Council lifts ban preventing pharmacies from selling DIY HIV test kits.
CanChew Plus CBD gum may eventually treat irritable bowel disease, Crohn’s disease, and ulcerative colitis.
Top news of the day from across the health care landscape.


Specialty Drugs: Year in Review 2016, Part I
Although there were not as many new specialty drug approvals in 2016, there were many already-approved specialty medications that received expanded indications.
Advances in the support of patients with HIV include remarkable new pharmaceutical therapies, collaborative care, outstanding patient support, and medication management.
Managing the complex environment of specialty products must be both strategic and tactical if you want to compete.
This year has seen different reactions on the congressional and state policy fronts concerning drug pricing.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Mark Tesell, PharmD, BCPS, discusses trends that could impact specialty pharmacy well into the future.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies can best demonstrate value as health care transitions to a value-based system.

Rinku A. Patel, PharmD, RPh, founder and CEO at KloudScipt, discusses effective integration of technology in the pharmacy setting.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Intellisphere, LLC. All Rights Reserved.